Bioxyne Ltd
Research Bioxyne Ltd (BXN) on Bullrun: market cap AUD 215.71M, P/E 23.9. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerBXN
- ExchangeAU
- CountryAustralia
- SectorConsumer Defensive
- IndustryPackaged Foods
- CurrencyAUD
- Market capAUD 215.71M
- P/E23.9
- Financial periodFY2024
- RevenueAUD 9.33M
- Revenue growth80.7%
- Net income-AUD 13.33M
- Free cash flow-AUD 4.09M
- Gross margin36.4%
Valuation Snapshot
latest market cap is AUD 215.71M; P/E is 23.9.
About Bioxyne Ltd
Bioxyne Limited, together with its subsidiaries, manufactures and distributes therapeutic goods, and health and wellness products in Australia, the United States, the United Kingdom, Czechia, Switzerland, France, Germany, and Japan. It operates through Pharmaceutical Manufacture and Wholesale Supply of Novel Medicines, Cannabis, Psilocybin, and MDMA; Manufacture and Distribution (Wholesale, Online, and Retail) of Consumer Health and Novel Food Products; and Wholesale of Patented Probiotics segments.
Frequently asked questions
What is Bioxyne Ltd's market cap?
Bioxyne Ltd's market capitalization is AUD 215.71M.
What is Bioxyne Ltd's P/E ratio?
Bioxyne Ltd's price-to-earnings (P/E) ratio is 23.9.
What does Bioxyne Ltd do?
Bioxyne Limited, together with its subsidiaries, manufactures and distributes therapeutic goods, and health and wellness products in Australia, the United States, the United Kingdom, Czechia, Switzerland, France, Germany, and Japan.